ArticleClinical & translational immunology2020

Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment.

Jonas Rm Van Audenaerde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.